New Enterprise Associates 16, L.P.

13D and 13G Filings

13D/G filings
13D on 3 securities
Location
Timonium, MD
CIK
0001694560
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Trevi Therapeutics, Inc. 13D/A Amendment 9
TRVI · 89532M101
10.5% 5/7/2026
Event 5/5/2026
Trevi Therapeutics, Inc. 13D/A Amendment 8
TRVI · 89532M101
11.6% 2/13/2026
Event 8/7/2025
Marker Therapeutics, Inc. 13D/A Amendment 5
MRKR · 57055L206
9.9% 11/17/2025
Event 11/13/2025
Marker Therapeutics, Inc. 13D/A Amendment 4
MRKR · 57055L206
12.6% 8/18/2025
Event 8/14/2025
Trevi Therapeutics, Inc. 13D/A Amendment 7
TRVI · 89532M101
12.0% 8/11/2025
Event 8/7/2025
Allakos Inc. 13D/A Amendment 1
ALLK · 01671P100
0% 5/16/2025
Event 5/15/2025
Trevi Therapeutics, Inc. 13D/A Amendment 6
TRVI · 89532M101
15.0% 3/20/2025
Event 3/18/2025
Marker Therapeutics, Inc. 13D/A Amendment 3
MRKR · 57055L206
15.2% 12/23/2024
Event 12/19/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.